Virtual voice technology enhances follow-up care for TAVI patients

Clinical follow-up using virtual voice technology helped identify complications after transcatheter aortic valve implantation (TAVI) with a high degree of patient satisfaction, according to research presented at ESC Congress 2024.

The course to forging long-term manufacturing partnerships for gene therapies – Pharmaceutical Technology

Image credit: Shutterstock/AuthenticVision The current adeno-associated virus (AAV) vector manufacturing landscape in 2024 is a “buyer’s market” with companies competing for clinical trial material manufacturing,

October 3, 2024

Meta Title: “Lonza Group Ltd Patent: Capsule Composition with Pullulan and Setting System

Share this article According to GlobalData’s company profile on Lonza Group, Nanoemulsion cosmetics was a key innovation area identified from patents. Lonza Group‘s grant share

April 1, 2024

Aviv Regev leads Genentech’s next revolution with AI

SOUTH SAN FRANCISCO — At Genentech, many of the company’s drug designers are making molecules for a machine that are, for lack of a better word,

December 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.